Padlock Therapeutics
Latest round
- Series A
Last raised
- Dec 2014
Total raised
- $23M
Investors
- 2
About Padlock Therapeutics
Padlock Therapeutics is a biopharmaceutical company focused on creating innovative treatments for autoimmune diseases.Founded in 2014 and headquartered in Cambridge, US, Padlock Therapeutics specializes in biopharmaceuticals for autoimmune diseases.00 mn, completing in April 2016.Padlock Therapeutics specializes in the development of innovative biopharmaceutical products aimed at addressing autoimmune diseases. The company's core offerings include proprietary drugs designed to modulate the immune system, thereby preventing or treating conditions such as rheumatoid arthritis and lupus. These products utilize advanced therapeutic techniques, potentially including small molecule inhibitors and biologics, which are targeted to provide precision treatment to patients. Padlock Therapeutics primarily serves healthcare providers and institutions, aiming to enhance the quality of life for patients suffering from chronic immune-related disorders.Padlock Therapeutics generates revenue through a combination of direct sales and strategic partnerships with healthcare institutions and pharmaceutical distributors. The company structures its transactions primarily through B2B relationships, where products are sold to hospitals and clinics that then administer these treatments to patients. Revenue streams are bolstered by ongoing collaborations with pharmaceutical companies for joint development and marketing efforts. Specific pricing plans for their flagship drug offerings are structured around both individual unit sales and bundled treatment packages, catering to the diverse needs of their client base.Padlock Therapeutics is focusing on expanding its product line and geographic reach. The company aims to launch new therapies designed to target additional autoimmune conditions within the next few years. The acquisition by Bristol-Myers Squibb is expected to enhance Padlock's operational capabilities and market access.
Who invested in Padlock Therapeutics
2 investors across 2 rounds
See all investors in Padlock Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Padlock Therapeutics
Who invested in Padlock Therapeutics?
Padlock Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Padlock Therapeutics raised?
Padlock Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Padlock Therapeutics last raise money?
Padlock Therapeutics's most recent round on record is a Series A, in Dec 2014.
What does Padlock Therapeutics do?
Padlock Therapeutics is a biopharmaceutical company focused on creating innovative treatments for autoimmune diseases.
Where is Padlock Therapeutics headquartered?
Padlock Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Padlock Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Padlock Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Padlock Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.